Matches in SemOpenAlex for { <https://semopenalex.org/work/W2289841322> ?p ?o ?g. }
- W2289841322 endingPage "574" @default.
- W2289841322 startingPage "559" @default.
- W2289841322 abstract "Monoclonal antibodies targeted against the immune checkpoint molecules CTLA-4 and PD-1 have recently obtained approval for the treatment of metastatic melanoma and advanced/refractory non small-cell lung cancers. Therefore, their use will not be limited anymore to selected hospitals involved in clinical trials. Indeed, they will be routinely prescribed in many cancer centers across the world. Besides their efficacy profile, these immune targeted agents also generate immune-related adverse events (irAEs). This new family of dysimmune toxicities remains largely unknown to the broad oncology community. Although severe irAEs remain rare (∼10% of cases under monotherapy), they can become life-threatening if not anticipated and managed appropriately. Over the last 5 years, Gustave Roussy has accumulated a significant experience in the prescription of immune checkpoint blockade (ICB) antibodies and the management of their toxicities. Together with the collaboration of Gustave Roussy's network of organ specialists with expertise in irAEs, we propose here some practical guidelines for the oncologist to help in the clinical care of patients under ICB immunotherapy." @default.
- W2289841322 created "2016-06-24" @default.
- W2289841322 creator A5001508020 @default.
- W2289841322 creator A5006832705 @default.
- W2289841322 creator A5009132075 @default.
- W2289841322 creator A5021624793 @default.
- W2289841322 creator A5021915992 @default.
- W2289841322 creator A5024442449 @default.
- W2289841322 creator A5024460514 @default.
- W2289841322 creator A5029587078 @default.
- W2289841322 creator A5030997594 @default.
- W2289841322 creator A5035622711 @default.
- W2289841322 creator A5038511140 @default.
- W2289841322 creator A5042924529 @default.
- W2289841322 creator A5047828139 @default.
- W2289841322 creator A5049103934 @default.
- W2289841322 creator A5049885447 @default.
- W2289841322 creator A5056132643 @default.
- W2289841322 creator A5059508363 @default.
- W2289841322 creator A5060793722 @default.
- W2289841322 creator A5065206480 @default.
- W2289841322 creator A5080861132 @default.
- W2289841322 creator A5082291642 @default.
- W2289841322 creator A5085234192 @default.
- W2289841322 creator A5089346180 @default.
- W2289841322 date "2016-04-01" @default.
- W2289841322 modified "2023-10-15" @default.
- W2289841322 title "Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper" @default.
- W2289841322 cites W1526068104 @default.
- W2289841322 cites W1546771547 @default.
- W2289841322 cites W1584290919 @default.
- W2289841322 cites W1725918626 @default.
- W2289841322 cites W1940241680 @default.
- W2289841322 cites W1950731067 @default.
- W2289841322 cites W1967980487 @default.
- W2289841322 cites W1969965329 @default.
- W2289841322 cites W1971989824 @default.
- W2289841322 cites W1973613923 @default.
- W2289841322 cites W1975889256 @default.
- W2289841322 cites W1987246352 @default.
- W2289841322 cites W1989679369 @default.
- W2289841322 cites W1990675339 @default.
- W2289841322 cites W1992987036 @default.
- W2289841322 cites W2000222100 @default.
- W2289841322 cites W2000289048 @default.
- W2289841322 cites W2001136531 @default.
- W2289841322 cites W2006156545 @default.
- W2289841322 cites W2008328365 @default.
- W2289841322 cites W2009942530 @default.
- W2289841322 cites W2010121426 @default.
- W2289841322 cites W2013030792 @default.
- W2289841322 cites W2017169228 @default.
- W2289841322 cites W2018077727 @default.
- W2289841322 cites W2020531896 @default.
- W2289841322 cites W2028226617 @default.
- W2289841322 cites W2031201427 @default.
- W2289841322 cites W2033009850 @default.
- W2289841322 cites W2052730188 @default.
- W2289841322 cites W2065101370 @default.
- W2289841322 cites W2068594961 @default.
- W2289841322 cites W2074557796 @default.
- W2289841322 cites W2083272188 @default.
- W2289841322 cites W2086264703 @default.
- W2289841322 cites W2095267413 @default.
- W2289841322 cites W2095826876 @default.
- W2289841322 cites W2100158834 @default.
- W2289841322 cites W2100274893 @default.
- W2289841322 cites W2103741075 @default.
- W2289841322 cites W2109653150 @default.
- W2289841322 cites W2116548718 @default.
- W2289841322 cites W2118747577 @default.
- W2289841322 cites W2118982164 @default.
- W2289841322 cites W2119896120 @default.
- W2289841322 cites W2122946645 @default.
- W2289841322 cites W2128035403 @default.
- W2289841322 cites W2129958914 @default.
- W2289841322 cites W2135738164 @default.
- W2289841322 cites W2137349687 @default.
- W2289841322 cites W2140254549 @default.
- W2289841322 cites W2144400223 @default.
- W2289841322 cites W2144657210 @default.
- W2289841322 cites W2145699122 @default.
- W2289841322 cites W2150188543 @default.
- W2289841322 cites W2156353875 @default.
- W2289841322 cites W2157899115 @default.
- W2289841322 cites W2158425309 @default.
- W2289841322 cites W2159220628 @default.
- W2289841322 cites W2160834915 @default.
- W2289841322 cites W2164838411 @default.
- W2289841322 cites W2164918836 @default.
- W2289841322 cites W2166107256 @default.
- W2289841322 cites W2166662937 @default.
- W2289841322 cites W2193279488 @default.
- W2289841322 cites W2222086386 @default.
- W2289841322 cites W2320537501 @default.
- W2289841322 cites W2320964824 @default.
- W2289841322 cites W2329842261 @default.
- W2289841322 cites W2335651231 @default.